SB 763,
as amended, begin deleteLenoend delete begin insertHillend insert. begin deleteJuvenile products: flame retardant chemicals. end deletebegin insertMedical professionals: probation.end insert
Existing law, the Medical Practice Act, establishes the Medical Board of California for the licensing, regulation, and discipline of physicians and surgeons. Existing law establishes the California Board of Podiatric Medicine within the Medical Board of California for the licensing, regulation, and discipline of podiatrists. Existing law, the Osteopathic Act, enacted by an initiative measure, establishes the Osteopathic Medical Board of California for the licensing and regulation of osteopathic physicians and surgeons and requires the Osteopathic Medical Board of California to enforce the Medical Practice Act with respect to its licensees. Existing law, the Naturopathic Doctors Act, establishes the Naturopathic Medicine Committee in the Osteopathic Medical Board of California for the licensing and regulation of naturopathic doctors. Existing law, the Chiropractic Act, enacted by an initiative measure, establishes the State Board of Chiropractic Examiners for the licensing and regulation of chiropractors. Existing law, the Acupuncture Licensure Act, establishes the Acupuncture Board for the licensing and regulation of acupuncturists. Existing law authorizes each of these regulatory entities to discipline its licensee by placing her or him on probation, as specified.
end insertbegin insertExisting law requires the Medical Board of California, the Osteopathic Medical Board of California, and the California Board of Podiatric Medicine to disclose to an inquiring member of the public and to post on their Internet Web sites specified information concerning each licensee including revocations, suspensions, probations, or limitations on practice.
end insertbegin insertThis bill would require the Medical Board of California, the Osteopathic Medical Board of California, the California Board of Podiatric Medicine, the State Board of Chiropractic Examiners, the Naturopathic Medicine Committee, and the Acupuncture Board by January 1, 2018, to make specified information with respect to licensees on probation and licensees practicing under a probationary license available to an inquiring member of the public, on any documents informing the public of individual probation orders, and in plain view on the profile Internet Web pages of licensees subject to probation, as specified.
end insertExisting federal law requires the Consumer Product Safety Commission to institute proceedings for the determination of an appropriate flammability standard if the commission finds that such a standard, including labeling, for a mattress, a fabric, related material, or product, may be needed to protect the public. Existing federal law authorizes a state to establish a flammability standard if, among other things, it provides a higher degree of protection from the risk of fire.
end deleteExisting state law, the Home Furnishings and Thermal Insulation Act, provides for the licensure and regulation of upholstered furniture manufacturers by the Bureau of Electronic and Appliance Repair, Home Furnishings, and Thermal Insulation. Existing state law requires every upholstered-furniture manufacturer to hold a furniture and bedding manufacturer’s license. Existing state law also requires every upholstered-furniture retailer to hold a retail furniture dealer’s license. A violation of the act is a crime.
end deleteExisting state law requires upholstered furniture and bedding to contain a specified label that is securely fastened in a manner approved by the bureau in an area open to visible view. Existing state law establishes a standard to produce upholstered furniture which is safer from the hazards associated with smoldering ignition. The standard provides methods for smolder resistance of cover fabrics, barrier materials, resilient filling materials, and decking materials for use in upholstered furniture.
end deleteThis bill would require a manufacturer of juvenile products, as defined, that sells juvenile products that contain added flame retardant chemicals, as defined, in California, to include a specified statement on a label, that meets certain labeling requirements.
end deleteThe bill would require the manufacturer of the juvenile product to retain sufficient documentation to show whether flame retardant chemicals were added to a juvenile product or component. The bill would provide that a written statement by the supplier of each component attesting that flame retardant chemicals were added or not added is sufficient to make this showing. The bill would require the bureau to assess a fine for a violation of the documentation requirement or for failure to provide, upon request, the required documentation to the bureau, as specified.
end deleteThe bill would require a manufacturer of a juvenile product sold in California, upon request, to provide to the bureau, within 30 days of the request, documentation establishing the accuracy of the flame retardant chemical statement on the label. The bill would require the bureau to provide the Department of Toxic Substances Control with samples of the juvenile product or components thereof sold in California from products that are not labeled as containing added flame retardant chemicals for testing for the presence of added flame retardant chemicals, as specified. If the department’s testing shows that a juvenile product that is not labeled as containing added flame retardant chemicals is mislabeled because it contains added flame retardant chemicals, the bill would authorize the bureau to assess fines for violations against manufacturers of the juvenile product and component manufacturers, as specified.
end deleteThe bill would require the bureau to make information about any determination issued pursuant to its provisions available to the public on its Internet Web site. The bill would also make it the duty of the bureau to receive consumer complaints.
end deleteThe bill would authorize the bureau to adopt regulations to carry out these provisions. The bill would provide that these provisions would apply to juvenile products manufactured on and after July 1, 2016, for retail sale in the state.
end deleteBecause a violation of the bill’s requirements would be a crime, the bill would impose a state-mandated local program.
end deleteThe Home Furnishings and Thermal Insulation Act requires that all mattresses and mattress sets manufactured for sale in this state, and all seating furniture sold or offered for sale for use in this state, be fire retardant, as defined. Existing law requires that all bedding products, other than mattresses and mattress sets, that the bureau determines to contribute to mattress bedding fires comply with specified regulations adopted by the bureau.
end deleteExisting law authorizes the chief of the bureau, subject to specified approval, to exempt items of upholstered furniture that are not deemed to be a serious fire hazard from these fire retardant requirements. Existing regulation exempts from these fire retardant requirements specified articles of upholstered furniture that include bassinets, booster seats, and car seats that are not used for, or in, facilities designed for the care or treatment of humans.
end deleteThis bill would exempt from the aforementioned fire retardant requirements under the act specified articles of juvenile products, as provided.
end deleteThe California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
end deleteThis bill would provide that no reimbursement is required by this act for a specified reason.
end deleteVote: majority.
Appropriation: no.
Fiscal committee: yes.
State-mandated local program: begin deleteyes end deletebegin insertnoend insert.
The people of the State of California do enact as follows:
begin insertSection 803.1 of the end insertbegin insertBusiness and Professions
2Codeend insertbegin insert is amended to read:end insert
(a) Notwithstanding any otherbegin delete provision ofend delete law, the
4Medical Board of California, the Osteopathic Medical Board of
5California, the California Board of Podiatric Medicine, and the
P5 1Physician Assistant Board shall disclose to an inquiring member
2of the public information regarding any enforcement actions taken
3against a licensee, including a former licensee, by the board or by
4another state or jurisdiction, including all of the following:
5(1) Temporary restraining orders issued.
6(2) Interim suspension orders issued.
7(3) Revocations, suspensions, probations, or limitations on
8practice ordered by the board, including those made part of a
9probationary order or stipulated agreement.
10(4) Public letters of reprimand issued.
11(5) Infractions, citations, or fines imposed.
12(b) Notwithstanding any otherbegin delete provision ofend delete law, in addition to
13the information provided in subdivision (a), the Medical Board of
14California, the Osteopathic Medical Board of California, the
15California Board of Podiatric Medicine, and the Physician Assistant
16Board shall disclose to an inquiring member of the public all of
17the following:
18(1) Civil judgments in any amount, whether or not vacated by
19a settlement after entry of the judgment, that were not reversed on
20appeal and arbitration awards in any amount of a claim or action
21for damages for death or personal injury caused by the physician
22and surgeon’s negligence, error, or omission in practice, or by his
23or her rendering of unauthorized professional services.
24(2) (A) All settlements in the possession, custody, or control
25of the board shall be disclosed for a licensee in the low-risk
26
category if there are three or more settlements for that licensee
27within the last 10 years, except for settlements by a licensee
28regardless of the amount paid where (i) the settlement is made as
29a part of the settlement of a class claim, (ii) the licensee paid in
30settlement of the class claim the same amount as the other licensees
31in the same class or similarly situated licensees in the same class,
32and (iii) the settlement was paid in the context of a case where the
33complaint that alleged class liability on behalf of the licensee also
34alleged a products liability class action cause of action. All
35settlements in the possession, custody, or control of the board shall
36be disclosed for a licensee in the high-risk category if there are
37four or more settlements for that licensee within the last 10 years
38except for settlements by a licensee regardless of the amount paid
39where (i) the settlement is made as a part of the settlement of a
40class claim, (ii) the licensee paid in settlement of the class claim
P6 1the same
amount as the other licensees in the same class or
2similarly situated licensees in the same class, and (iii) the
3settlement was paid in the context of a case where the complaint
4that alleged class liability on behalf of the licensee also alleged a
5products liability class action cause of action. Classification of a
6licensee in either a “high-risk category” or a “low-risk category”
7depends upon the specialty or subspecialty practiced by the licensee
8and the designation assigned to that specialty or subspecialty by
9the Medical Board of California, as described in subdivision (f).
10For the purposes of this paragraph, “settlement” means a settlement
11of an action described in paragraph (1) entered into by the licensee
12on or after January 1, 2003, in an amount of thirty thousand dollars
13($30,000) or more.
14(B) The board shall not disclose the actual dollar amount of a
15settlement but shall put the number and amount of the settlement
16in context by doing
the following:
17(i) Comparing the settlement amount to the experience of other
18licensees within the same specialty or subspecialty, indicating if
19it is below average, average, or above average for the most recent
2010-year period.
21(ii) Reporting the number of years the licensee has been in
22practice.
23(iii) Reporting the total number of licensees in that specialty or
24subspecialty, the number of those who have entered into a
25settlement agreement, and the percentage that number represents
26of the total number of licensees in the specialty or subspecialty.
27(3) Current American Board of Medical Specialties certification
28or board equivalent as certified by the Medical Board of California,
29the Osteopathic Medical Board of California, or the California
30Board of
Podiatric Medicine.
31(4) Approved postgraduate training.
32(5) Status of the license of a licensee. By January 1, 2004, the
33Medical Board of California, the Osteopathic Medical Board of
34California, and the California Board of Podiatric Medicine shall
35adopt regulations defining the status of a licensee. The board shall
36employ this definition when disclosing the status of a licensee
37pursuant to Section 2027.begin insert By January 1, 2018, the Medical Board
38of California, the Osteopathic Medical Board of California, and
39the California Board of Podiatric Medicine shall include the
40information described in paragraph (1) of subdivision (i).end insert
P7 1(6) Any summaries of hospital disciplinary actions that result
2in the termination or
revocation of a licensee’s staff privileges for
3medical disciplinary cause or reason, unless a court finds, in a final
4judgment, that the peer review resulting in the disciplinary action
5was conducted in bad faith and the licensee notifies the board of
6that finding. In addition, any exculpatory or explanatory statements
7submitted by the licentiate electronically pursuant to subdivision
8(f) of that section shall be disclosed. For purposes of this paragraph,
9“peer review” has the same meaning as defined in Section 805.
10(c) Notwithstanding any otherbegin delete provision ofend delete law, the Medical
11Board of California, the Osteopathic Medical Board of California,
12the California Board of Podiatric Medicine, and the Physician
13Assistant Board shall disclose to an inquiring member of the public
14information received regarding felony convictions of a physician
15and surgeon or doctor of podiatric medicine.
16(d) The Medical Board of California, the Osteopathic Medical
17Board of California, the California Board of Podiatric Medicine,
18and the Physician Assistant Board may formulate appropriate
19disclaimers or explanatory statements to be included with any
20information released, and may by regulation establish categories
21of information that need not be disclosed to an inquiring member
22of the public because that information is unreliable or not
23sufficiently related to the licensee’s professional practice. The
24Medical Board of California, the Osteopathic Medical Board of
25
California, the California Board of Podiatric Medicine, and the
26Physician Assistant Board shall include the following statement
27when disclosing information concerning a settlement:
28
30“Some studies have shown that there is no significant correlation
31between malpractice history and a doctor’s competence. At the
32same time, the State of California believes that consumers should
33have access to malpractice information. In these profiles, the State
34of California has given you information about both the malpractice
35settlement history for the doctor’s specialty and the doctor’s history
36of settlement payments only if in
the last 10 years, the doctor, if
37in a low-risk specialty, has three or more settlements or the doctor,
38if in a high-risk specialty, has four or more settlements. The State
39of California has excluded some class action lawsuits because
40those cases are commonly related to systems issues such as product
P8 1liability, rather than questions of individual professional
2competence and because they are brought on a class basis where
3the economic incentive for settlement is great. The State of
4California has placed payment amounts into three statistical
5categories: below average, average, and above average compared
6to others in the doctor’s specialty. To make the best health care
7decisions, you should view this information in perspective. You
8could miss an opportunity for high-quality care by selecting a
9doctor based solely on malpractice history.
10When considering malpractice data, please keep in mind:
11Malpractice histories tend to vary
by specialty. Some specialties
12are more likely than others to be the subject of litigation. This
13report compares doctors only to the members of their specialty,
14not to all doctors, in order to make an individual doctor’s history
15more meaningful.
16This report reflects data only for settlements made on or after
17January 1, 2003. Moreover, it includes information concerning
18those settlements for a 10-year period only. Therefore, you should
19know that a doctor may have made settlements in the 10 years
20immediately preceding January 1, 2003, that are not included in
21this report. After January 1, 2013, for doctors practicing less than
2210 years, the data covers their total years of practice. You should
23take into account the effective date of settlement disclosure as well
24as how long the doctor has been in practice when considering
25malpractice averages.
26The incident causing the malpractice claim may have happened
27years before a payment
is finally made. Sometimes, it takes a long
28time for a malpractice lawsuit to settle. Some doctors work
29primarily with high-risk patients. These doctors may have
30malpractice settlement histories that are higher than average
31because they specialize in cases or patients who are at very high
32risk for problems.
33Settlement of a claim may occur for a variety of reasons that do
34not necessarily reflect negatively on the professional competence
35or conduct of the doctor. A payment in settlement of a medical
36malpractice action or claim should not be construed as creating a
37presumption that medical malpractice has occurred.
38You may wish to discuss information in this report and the
39general issue of malpractice with your doctor.”
40
P9 2(e) The Medical Board of California, the Osteopathic Medical
3Board of California, the California Board of Podiatric Medicine,
4and the Physician Assistant Board shall, by regulation, develop
5standard terminology that accurately describes the different types
6of disciplinary filings and actions to take against a licensee as
7described in paragraphs (1) to (5), inclusive, of subdivision (a). In
8providing the public with information about a licensee via the
9Internet pursuant to Section 2027, the Medical Board of California,
10the Osteopathic Medical Board of California, the California Board
11of Podiatric Medicine, and the Physician Assistant Board shall not
12use the terms “enforcement,” “discipline,” or similar language
13implying a sanction unless the physician and surgeon has been the
14subject of one of the actions described in paragraphs (1) to (5),
15inclusive, of subdivision (a).
16(f) The Medical Board of California shall adopt regulations no
17later than July 1, 2003, designating each specialty and subspecialty
18practice area as either high risk or low risk. In promulgating these
19regulations, the board shall consult with commercial underwriters
20of medical malpractice insurance companies, health care systems
21that self-insure physicians and surgeons, and representatives of
22the California medical specialty societies. The board shall utilize
23the carriers’ statewide data to establish the two risk categories and
24the averages required by subparagraph (B) of paragraph (2) of
25subdivision (b). Prior to issuing regulations, the board shall
26convene public meetings with the medical malpractice carriers,
27self-insurers, and specialty representatives.
28(g) The Medical Board of California, the Osteopathic Medical
29Board of California, the California Board of Podiatric Medicine,
30begin insert
andend insert the Physician Assistant Board shall provide each licensee,
31including a former licensee under subdivision (a), with a copy of
32the text of any proposed public disclosure authorized by this section
33prior to release of the disclosure to the public. The licensee shall
34have 10 working days from the date the board provides the copy
35of the proposed public disclosure to propose corrections of factual
36inaccuracies. Nothing in this section shall prevent the board from
37disclosing information to the public prior to the expiration of the
3810-day period.
39(h) Pursuant to subparagraph (A) of paragraph (2) of subdivision
40(b), the specialty or subspecialty information required by this
P10 1section shall group physicians by specialty board recognized
2pursuant to paragraph (5) of subdivision (h) of Section 651 unless
3a different grouping would be more valid and the board, in its
4statement of reasons for its regulations,
explains why the validity
5of the grouping would be more valid.
6
(i) (1) By January 1, 2018, the Medical Board of California,
7the Osteopathic Medical Board of California, and the California
8Board of Podiatric Medicine shall make the following information,
9with respect to licensees on probation and licensees practicing
10under a probationary license, available to the public as specified
11in this subdivision, paragraph (5) of subdivision (b) of this section,
12and clause (ii) of subparagraph (C) of paragraph (3) of subdivision
13(a) of Section 2027:
14
(A) For probation imposed pursuant to a stipulated settlement,
15the causes alleged in the operative accusation along with a
16designation
identifying those causes by which the licensee has
17expressly admitted guilt. The information shall include a statement
18that acceptance of the settlement is not an admission of guilt unless
19the licensee has expressly admitted guilt and that all allegations
20not expressly admitted to remain unproven.
21
(B) For probation imposed by an adjudicated decision of the
22board, the causes for probation stated in the final probationary
23order.
24
(C) For licensees granted a probationary license, the causes
25by which a probationary license was imposed.
26
(D) The length of the probation and the end date.
27
(E) All practice restrictions placed on the licensee by the board.
28
(2) By January 1, 2018, the Medical Board of California, the
29Osteopathic Medical Board of California, and the California Board
30of Podiatric Medicine shall include the information listed in
31paragraph (1) on any board documents informing the public of
32individual probation orders and probationary licenses, including,
33but not limited to, newsletters.
begin insertSection 1006 is added to the end insertbegin insertBusiness and Professions
35Codeend insertbegin insert, to read:end insert
(a) By January 1, 2018, the board shall make the
37following information, with respect to licensees on probation and
38licensees practicing under a probationary license, available to the
39public as specified in subdivision (b):
P11 1
(1) For probation imposed pursuant to a stipulated settlement,
2the causes alleged in the operative accusation along with a
3designation identifying those causes by which the licensee has
4expressly admitted guilt. The information shall include a statement
5that acceptance of the settlement is not an admission of guilt unless
6the licensee has expressly admitted guilt and that all allegations
7not expressly admitted to remain unproven.
8
(2) For probation imposed by an
adjudicated decision of the
9board, the causes for probation stated in the final probationary
10order.
11
(3) For a licensee granted a probationary license, the causes
12by which the probationary license was imposed.
13
(4) The length of the probation and the end date.
14
(5) All practice restrictions placed on the licensee by the board.
15
(b) By January 1, 2018, the board shall provide the information
16listed in subdivision (a) as follows:
17
(1) To an inquiring member of the public.
18
(2) On any board documents informing the public of individual
19probation orders and probationary licenses, including, but not
20limited to, newsletters.
21
(3) In plain view on the licensee’s profile page on the board’s
22Internet Web site.
begin insertSection 2027 of the end insertbegin insertBusiness and Professions Codeend insertbegin insert is
24amended to read:end insert
(a) The board shall post on its Internet Web site the
26following information on the current status of the license for all
27current and former licensees:
28(1) Whether or not the licensee is presently in good standing.
29(2) Current American Board of Medical Specialties certification
30or board equivalent as certified by the board.
31(3) Any of the following enforcement actions or proceedings
32to which the licensee is actively subjected:
33(A) Temporary restraining orders.
34(B) Interim suspension orders.
35(C) begin insert(i)end insertbegin insert end insertRevocations, suspensions, probations, or limitations on
36practice ordered by the board or the board of another state or
37jurisdiction, including those made part of a probationary order or
38stipulated agreement.
39
(ii) By January 1, 2018, the board, the Osteopathic Medical
40Board of California, and the California Board of Podiatric
P12 1Medicine shall include, in plain view on the BreEZe profile Internet
2Web page of each licensee subject to probation or a probationary
3license, the information described in paragraph (1) of subdivision
4(i) of Section 803.1. For purposes of this clause, a BreEZe profile
5Internet Web page is a profile Internet Web page on the BreEZe
6system pursuant
to Section 210.
7(D) Current accusations filed by the Attorney General, including
8those accusations that are on appeal. For purposes of this paragraph,
9“current accusation” means an accusation that has not been
10dismissed, withdrawn, or settled, and has not been finally decided
11upon by an administrative law judge and the board unless an appeal
12of that decision is pending.
13(E) Citations issued that have not been resolved or appealed
14within 30 days.
15(b) The board shall post on its Internet Web site all of the
16following historical information in its possession, custody, or
17control regarding all current and former licensees:
18(1) Approved postgraduate training.
19(2) Any
final revocations and suspensions, or other equivalent
20actions, taken against the licensee by the board or the board of
21another state or jurisdiction or the surrender of a license by the
22licensee in relation to a disciplinary action or investigation,
23including the operative accusation resulting in the license surrender
24or discipline by the board.
25(3) Probation or other equivalent action ordered by the board,
26or the board of another state or jurisdiction, completed or
27terminated, including the operative accusation resulting in the
28discipline by the board.
29(4) Any felony convictions. Upon receipt of a certified copy of
30an expungement order granted pursuant to Section 1203.4 of the
31Penal Code from a licensee, the board shall, within six months of
32receipt of the expungement order, post notification of the
33expungement order and the date thereof on its Internet Web site.
34(5) Misdemeanor convictions resulting in a disciplinary action
35or accusation that is not subsequently withdrawn or dismissed.
36Upon receipt of a certified copy of an expungement order granted
37pursuant to Section 1203.4 of the Penal Code from a licensee, the
38board shall, within six months of receipt of the expungement order,
39post notification of the expungement order and the date thereof on
40its Internet Web site.
P13 1(6) Civil judgments issued in any amount, whether or not
2vacated by a settlement after entry of the judgment, that were not
3reversed on appeal, and arbitration awards issued in any amount,
4for a claim or action for damages for death or personal injury
5caused by the physician and surgeon’s negligence, error, or
6omission in practice, or by his or her rendering of unauthorized
7professional services.
8(7) Except as
provided in subparagraphs (A) and (B), a summary
9of any final hospital disciplinary actions that resulted in the
10termination or revocation of abegin delete licensee'send deletebegin insert licensee’send insert hospital staff
11privileges for a medical disciplinary cause or reason. The posting
12shall provide any additional explanatory or exculpatory information
13submitted by the licensee pursuant to subdivision (f) of Section
14805. The board shall also post on its Internet Web site a factsheet
15that explains and provides information on the reporting
16requirements under Section 805.
17(A) If a licensee’s hospital staff privileges are restored and the
18licensee notifies the board of the restoration, the information
19pertaining to the termination or revocation of those privileges shall
20remain posted on the Internet Web site for a period of 10 years
21from the restoration date of the privileges, and at the end of that
22period shall be removed.
23(B) If a court finds, in a final judgment, that peer review
24resulting in a hospital disciplinary action was conducted in bad
25faith and the licensee notifies the board of that finding, the
26information concerning that hospital disciplinary action posted on
27the Internet Web site shall be immediately removed. For purposes
28of this subparagraph, “peer review” has the same meaning as
29defined in Section 805.
30(8) Public letters of reprimand issued within the past 10 years
31by the board or the board of another state or jurisdiction, including
32the operative accusation, if any, resulting in discipline by the board.
33(9) Citations issued within the last three years that have been
34resolved by payment of the administrative fine or compliance with
35the order of abatement.
36(10) All settlements within the last five years in the possession,
37custody, or control of the board shall be disclosed for a licensee
38in the low-risk category if there are three or more settlements for
39that licensee within the last five years, and for a licensee in the
40high-risk category if there are four or more settlements for that
P14 1licensee within the last five years. Classification of a licensee in
2either a “high-risk category” or a “low-risk” category depends
3upon the specialty or subspecialty practiced by the licensee and
4the designation assigned to that specialty or subspecialty by the
5board pursuant to subdivision (f) of Section 803.1.
6(A) For the purposes of this paragraph, “settlement” means a
7settlement in an amount of thirty thousand dollars ($30,000) or
8more of any claim or action for damages for death or personal
9injury caused by the physician and surgeon’s negligence, error, or
10omission in practice, or by his or her
rendering of unauthorized
11professional services.
12(B) For the purposes of this paragraph, “settlement” does not
13include a settlement by a licensee, regardless of the amount paid,
14when (i) the settlement is made as a part of the settlement of a
15class claim, (ii) the amount paid in settlement of the class claim
16is the same amount paid by the other licensees in the same class
17or similarly situated licensees in the same class, and (iii) the
18settlement was paid in the context of a case for which the complaint
19that alleged class liability on behalf of the licensee also alleged a
20products liability class action cause of action.
21(C) The board shall not disclose the actual dollar amount of a
22settlement, but shall disclose settlement information in the same
23manner and with the same disclosures required under subparagraph
24(B) of paragraph (2) of subdivision (b) of Section 803.1.
25(11) Appropriate disclaimers and explanatory statements to
26accompany the information described in paragraphs (1) to (10),
27inclusive, including an explanation of what types of information
28are not disclosed. These disclaimers and statements shall be
29developed by the board and shall be adopted by regulation.
30(c) The board shall provide links to other Internet Web sites
31that provide information on board certifications that meet the
32requirements of subdivision (h) of Section 651. The board may
33also provide links to any other Internet Web sites that provide
34information on the affiliations of licensed physicians and surgeons.
35The board may provide links to other Internet Web sites on the
36Internet that provide information on health care service plans,
37health insurers, hospitals, or other facilities.
begin insertSection 3663.5 is added to the end insertbegin insertBusiness and Professions
39Codeend insertbegin insert, to read:end insert
(a) By January 1, 2018, the committee shall make the
2following information, with respect to naturopathic doctors on
3probation and naturopathic doctors practicing under a
4probationary license, available to the public as specified in
5subdivision (b):
6
(1) For probation imposed pursuant to a stipulated settlement,
7the causes alleged in the operative accusation along with a
8designation identifying those causes by which the naturopathic
9doctor has expressly admitted guilt. The information shall include
10a statement that acceptance of the settlement is not an admission
11of guilt unless the naturopathic doctor has expressly admitted guilt
12and that all allegations not expressly admitted to remain unproven.
13
(2) For probation imposed by an adjudicated decision of the
14committee, the causes for probation stated in the final probationary
15order.
16
(3) For a naturopathic doctor granted a probationary license,
17the causes by which the probationary license was imposed.
18
(4) The length of the probation and the end date.
19
(5) All practice restrictions placed on the naturopathic doctor
20by the committee.
21
(b) By January 1, 2018, the committee shall provide the
22information listed in subdivision (a) as follows:
23
(1) To an inquiring member of the public.
24
(2) On any committee documents
informing the public of
25individual probation orders and probationary licenses, including,
26but not limited to, newsletters.
27
(3) In plain view on the BreEZe profile Internet Web page of a
28naturopathic doctor subject to probation or a probationary license.
begin insertSection 4962 is added to the end insertbegin insertBusiness and Professions
30Codeend insertbegin insert, to read:end insert
(a) By January 1, 2018, the board shall make the
32following information, with respect to licensees on probation and
33licensees practicing under a probationary license, available to the
34public as specified in subdivision (b):
35
(1) For probation imposed pursuant to a stipulated settlement,
36the causes alleged in the operative accusation along with a
37designation identifying those causes by which the licensee has
38expressly admitted guilt. The information shall include a statement
39that acceptance of the settlement is not an admission of guilt unless
P16 1the licensee has expressly admitted guilt and that all allegations
2not expressly admitted to remain unproven.
3
(2) For probation imposed by an
adjudicated decision of the
4board, the causes for probation stated in the final probationary
5order.
6
(3) For a licensee granted a probationary license, the causes
7by which the probationary license was imposed.
8
(4) The length of the probation and the end date.
9
(5) All practice restrictions placed on the licensee by the board.
10
(b) By January 1, 2018, the board shall provide the information
11listed in subdivision (a) as follows:
12
(1) To an inquiring member of the public.
13
(2) On any board documents informing the public of individual
14probation orders and probationary licenses, including, but not
15limited to, newsletters.
16
(3) Upon availability of a licensee’s BreEZe profile Internet
17Web page on the BreEZe system pursuant to Section 210, in plain
18view on the BreEZe profile Internet Web page of a licensee subject
19to probation or a probationary license.
Section 19095 is added to the Business and
21Professions Code, to read:
(a) For the purposes of this section, the following
23definitions shall apply:
24(1) “Component” means the separate constituent parts of juvenile
25products sold in California, specifically cover fabrics, barrier
26materials, resilient filling materials, and plastic parts.
27(2) “Juvenile product” means a product subject to the Home
28Furnishings and Thermal Insulation Act and intended for use by
29infants and children under 12 years of age, such as a bassinet,
30booster seat, infant car seat, changing pad, floor play mat,
31highchair, highchair pad, infant bouncer, infant carrier, infant seat,
32infant swing, infant walker, nursing pad, nursing pillow, playpen
33side pad, playard, portable hook-on
chair, stroller, children’s nap
34mat, and infant foam crib mattress. Products subject to the
35requirements of Section 19094 are not subject to the requirements
36of this section. “Juvenile product” does not include products
37required to meet federal flammability standards contained in Part
381632 or 1633 of Title 16 of the Code of Federal Regulations.
P17 1(3) “Added flame retardant chemicals” means flame retardant
2chemicals that are present in any juvenile product or component
3thereof at levels above 1,000 parts per million.
4(4) “Flame retardant chemical” means any chemical or chemical
5compound for which a functional use is to resist or inhibit the
6spread of fire. Flame retardant chemicals include, but are not
7limited to, halogenated, phosphorous-based, nitrogen-based, and
8nanoscale flame retardants, flame retardant chemicals listed as
9“designated chemicals” pursuant to Section 105440 of the
Health
10and Safety Code, and any chemical or chemical compound for
11which “flame retardant” appears on the substance Safety Data
12Sheet (SDS) pursuant to Section 1910.1200(g) of Title 29 of the
13Code of Federal Regulations.
14(5) “Chemical” means either of the following:
15(A) An organic or inorganic substance of a particular molecular
16identity, including any combination of those substances occurring,
17in whole or in part, as a result of a chemical reaction or occurring
18in nature, and any element, ion, or uncombined radical, and any
19degradate, metabolite, or reaction product of a substance with a
20particular molecular identity.
21(B) A chemical
ingredient, which means a substance comprising
22one or more substances described in subparagraph (A).
23(6) “Molecular identity” means the substance’s properties listed
24below:
25(A) Agglomeration state.
26(B) Bulk density.
27(C) Chemical composition, including surface coating.
28(D) Crystal structure.
29(E) Dispersibility.
30(F) Molecular structure.
31(G) Particle density.
32(H) Particle size, size distribution, and surface area.
33(I) Physical form and shape, at room temperature and pressure.
34(J) Physicochemical properties.
35(K) Porosity.
36(L) Solubility in water and biologically relevant fluids.
37(M) Surface charge.
38(N) Surface reactivity.
39(7) “Department” means the Department of Toxic Substances
40Control.
P18 1(8) “Consumer Price Index” means the Consumer Price Index
2for All Urban Consumers published by the Bureau of Labor
3Statistics.
4(b) (1) A manufacturer of juvenile products sold in California
5shall
include, for juvenile products containing added flame
6retardant chemicals, a label in plain view, stating the following:
8“The State of California has determined that this product does
9not pose a serious fire hazard. The state has identified many flame
10retardant chemicals as being known to, or strongly suspected of,
11adversely impacting human health or development.
12The fabric, filling, and plastic parts of this product contain added
13flame retardant chemicals.”
14
15(2) The label for juvenile products shall comply with the labeling
16requirements of subdivisions (a), (b), and (e) of Section 1126 of
17Title 4 of the California Code of Regulations. The type on the label
18need not be in all capital
letters.
19(c) (1) The manufacturer of the juvenile product sold in
20California shall retain documentation to show whether flame
21retardant chemicals were added. A written statement by the supplier
22of each component of a juvenile product attesting either that flame
23retardant chemicals were added or not added shall be sufficient
24documentation.
25(2) The bureau shall ensure compliance with the labeling and
26documentation requirements in this section.
27(3) (A) Upon request, a manufacturer of a juvenile product sold
28in California shall provide to the bureau, within 30 days of the
29request, documentation establishing the accuracy of the flame
30retardant chemical
statement on the label required by subdivision
31(b) or documentation that the juvenile product does not contain an
32added flame retardant.
33(B) The bureau shall assess fines of not less than two thousand
34five hundred dollars ($2,500) but not more than fifteen thousand
35dollars ($15,000) in accordance with the factors described in
36subdivision (d) for the failure of the manufacturer of the juvenile
37product to maintain the documentation required by this section,
38or for the failure of the manufacturer of the juvenile product to
39provide, upon request, the documentation required by this section
40to the bureau. These fines shall replace any other fines in this article
P19 1for a violation of the
documentation requirements of this section.
2This subparagraph does not alter or amend any other penalty
3otherwise imposed by this article.
4(C) A manufacturer of juvenile products sold in California and
5component suppliers shall be jointly and severally liable for
6violations of the documentation required in this section.
7(D) (i) The bureau shall provide the Department of Toxic
8Substances Control with a selection of samples from juvenile
9products that are not labeled as containing added flame retardant
10chemicals
for testing for the presence of added flame retardant
11chemicals. The samples shall be from the components identified
12in paragraph (1) of subdivision (a). The bureau shall select samples
13based on consultation with the department, taking into account a
14range of manufacturers and types of juvenile products. The bureau
15and the department shall consult on the tests to be conducted by
16the department. The department shall provide the results of any
17completed test to the bureau. The bureau shall reimburse the
18department for the cost of testing for the presence of added flame
19retardant chemicals in juvenile products that are not labeled as
20containing added flame retardant chemicals.
21(ii) No later than August 1 of each fiscal year, the bureau shall
22assess available resources and determine the number of tests to be
23conducted in the corresponding fiscal year, pursuant to this
24subparagraph.
25(E) (i) If the department’s testing shows that a juvenile product
26not labeled as containing added flame retardant chemicals is
27mislabeled because it contains added flame retardant chemicals,
28the bureau may assess fines for violations against manufacturers
29of
the juvenile product and component manufacturers to be held
30jointly and severally liable for the violation.
31(ii) A fine for a violation of this subparagraph relating to
32mislabeling shall be assessed in accordance with the factors
33described in subdivision (d) and the following schedule:
34(I) The fine for the first violation shall be not less than one
35thousand dollars ($1,000) but not more than two thousand five
36hundred dollars ($2,500).
37(II) The fine for the second violation shall be not less than two
38thousand five hundred dollars ($2,500) but not more than five
39thousand dollars ($5,000).
P20 1(III) The fine for the third violation shall be not less than five
2thousand dollars ($5,000) but not more than seven thousand five
3hundred dollars ($7,500).
4(IV) The fine for any subsequent violation shall be not less than
5seven thousand five hundred dollars ($7,500) but not more than
6ten thousand dollars ($10,000).
7(iii) The fines in clause (ii) shall replace any other fines in this
8article for a violation of the testing requirements of this section.
9This clause does not alter or amend any other penalty otherwise
10imposed by this article.
11(iv) If the department’s testing
shows that a juvenile product
12that is not labeled as containing added flame retardant chemicals
13is mislabeled because it contains added flame retardant chemicals,
14in addition to a fine or any other request, the bureau may request
15that the label required by subdivision (b) for juvenile products that
16belong to the same stock keeping unit (SKU) currently produced
17by the manufacturer be corrected to reflect that flame retardant
18chemicals are added to the juvenile product.
19(v) If the department’s testing shows that a juvenile product
that
20is not labeled as containing added flame retardant chemicals
is
21mislabeled because it contains added flame retardant chemicals,
22in addition to a fine or any other request, the bureau may request
23additional testing of more products belonging to the same stock
24keeping unit (SKU) at the manufacturer’s expense to verify the
25accuracy of the label required by subdivision (b) for juvenile
26products if the manufacturer wishes to retain the “contains NO
27added flame retardant chemicals” designation on the label required
28by subdivision (b).
29(d) (1) The bureau shall make information about any
30determination issued pursuant to this section available to the public
31on its Internet Web site.
32(2) In determining the amount of the fine for violations of this
33section, the bureau shall consider the following factors:
34(A) The nature and severity of the violation.
35(B) The good or bad faith of the cited person.
36(C) The history of previous violations.
37(D) Evidence that the violation was willful.
38(E) The extent to which
the cited person or entity has cooperated
39with the bureau.
P21 1(3) (A) The bureau shall adjust all minimum and maximum
2fines imposed by this section for inflation every five years.
3(B) The adjustment shall be equivalent to the percentage, if any,
4that the Consumer Price Index at the time of adjustment exceeds
5the Consumer Price Index at the time this section goes into effect.
6Any increase determined under this paragraph shall be rounded as
7follows:
8(i) In multiples of ten dollars ($10) in the case of penalties less
9than or equal to one hundred dollars ($100).
10(ii) In multiples of one hundred dollars ($100) in the case of
11penalties greater than one hundred dollars ($100) but less than or
12equal to one thousand dollars ($1,000).
13(iii) In multiples of one thousand dollars ($1,000) in the case
14of penalties greater than one thousand dollars ($1,000).
15(4) It shall be the duty of the bureau to receive complaints from
16consumers concerning juvenile products sold in California.
17(e) The bureau may adopt regulations pursuant to the
18Administrative Procedure Act (Chapter 3.5 (commencing with
19Section 11340) of Part 1 of Division 3 of Title 2 of
the Government
20Code) to carry out this section.
21(f) Electric and electronic units or components, including, but
22not limited to, power cords or power supply units, motor
23assemblies, Bluetooth modules, vibration units, light and sound
24units, circuit boards and wiring, are excluded when determining
25whether a product contains added flame retardants for purposes
26of the labeling requirements of this section. The chief may, at his
27or her discretion, subject to the approval of the director, clarify
28this list in regulation.
29(g) This section shall apply to juvenile products manufactured
30on and after July 1, 2016, for retail sale in the state.
Section 19161.4 is added to the Business and
32Professions Code, to read:
The requirements of Section 19161 shall not apply
34to juvenile products, as defined in Section 19095.
No reimbursement is required by this act pursuant to
36Section 6 of Article XIII B of the California Constitution because
37the only costs that may be incurred by a local agency or school
38district will be incurred because this act creates a new crime or
39infraction, eliminates a crime or infraction, or changes the penalty
40for a crime or infraction, within the meaning of Section 17556 of
P22 1the Government Code, or changes the definition of a crime within
2the meaning of Section 6 of Article XIII B of the California
3Constitution.
O
92